Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Liver Cirrhosis, Biliary | Phase 2 | - | - | |
Crohn Disease | Preclinical | NL | 01 Jan 2016 | |
Crohn Disease | Preclinical | BE | 01 Jan 2016 | |
Primary Biliary Cholangitis | Preclinical | NL | 01 May 2015 | |
Primary Biliary Cholangitis | Preclinical | GB | 01 May 2015 | |
Liver Cirrhosis, Biliary | Preclinical | IT | - |